Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Aptinyx Inc. (APTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/10/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
07/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/02/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/24/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/24/2023 RW Form RW - Registration Withdrawal Request:
05/23/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
05/18/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/11/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/05/2023 8-K Quarterly results
04/28/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/25/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
03/16/2023 SC 13D/A Longitude Capital Partners II, LLC reports a 0.3% stake in APTINYX INC.
03/01/2023 8-K Quarterly results
02/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Aptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate Update"
01/20/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/08/2022 8-K Quarterly results
12/01/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
08/25/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Aptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’ s Disease and Dementia with Lewy Bodies"
08/12/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia"
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "Aptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights"
06/24/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/24/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/24/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/24/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/10/2022 8-K Quarterly results
05/31/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy